Teradyne (TER) Tops Q3 EPS by 6c, Q4 Guidance Beats

Teradyne (NASDAQ: TER) reported Q3 EPS of $1.18, $0.06 better than the analyst estimate of $1.12. Revenue for the quarter came in at $819 million versus the consensus estimate of $770.29 million.

GUIDANCE:

Teradyne sees Q4 2020 EPS of $0.90-$1.06, versus the consensus of $0.50. Teradyne sees Q4 2020 revenue of $680-740 million, versus the consensus of $543 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
• Global-e Online (GLBE) Tops Q2 EPS by 16c ; Offers Guidance
• Milestone Pharmaceuticals Inc. (MIST) Misses Q2 EPS by 2c